Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Dyspepsia, Malaise
Clinical narrative: I recently have covid; I am having very bad indigestion; Not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I recently have covid), DYSPEPSIA (I am having very bad indigestion) and MALAISE (Not feeling well) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Had Two doses). Past adverse reactions to the above products included COVID-19 with Pfizer.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (I recently have covid), DYSPEPSIA (I am having very bad indigestion) and MALAISE (Not feeling well). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment, at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ALKA-SELTZER) at an unspecified dose and frequency. At the time of the report, COVID-19 (I recently have covid), DYSPEPSIA (I am having very bad indigestion) and MALAISE (Not feeling well) outcome was unknown.            No Concomitant medication reported. It had been reported that the patient had two doses of Pfizer (suspect name not clarified hence, captured as Unspecified Product) and one booster of Moderna (suspect name not clarified hence, captured as Unspecified Product).   Company comment: This is a spontaneous case concerning a patient of unknown age and gender, with no reported medical history, who experienced the non-serious unexpected, AESI of COVID-19. The event occurred after the mRNA-1273 vaccine, received as the booster dose of COVID-19 vaccination schedule, temporal association cannot be assessed due to lack of information on onset date of the event and vaccination date. Patient received treatment with nirmatrelvir, ritonavir. The outcome of the event was reported as unknown. Additionally, Interchange of vaccine products (vaccination with two doses of COVID-19 vaccine Tozinameran dates not provided) was noted in the case. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a patient of unknown age and gender, with no reported medical history, who experienced the non-serious unexpected, AESI of COVID-19. The event occurred after the mRNA-1273 vaccine, received as the booster dose of COVID-19 vaccination schedule, temporal association cannot be assessed due to lack of information on onset date of the event and vaccination date. Patient received treatment with nirmatrelvir, ritonavir. The outcome of the event was reported as unknown. Additionally, Interchange of vaccine products (vaccination with two doses of COVID-19 vaccine Tozinameran dates not provided) was noted in the case. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.